Weekly signal · ALAB · Technology

Astera Labs, Inc. (ALAB) posts a 216.4% 12-week semiconductor rally

The cloud and AI infrastructure chip supplier remains in an active trend as participation runs slightly above its recent weekly norm.

Astera Labs, Inc.
Latest367.15 USD
1W move15.8%
Volume1.1x
TrendActive
Weekly market chart visual for Astera Labs stock with semiconductor connectivity hardware.

Market update

What happened

Astera Labs, Inc. (ALAB) closed at 367.15 USD for the week ended June 12, rising 15.8% in weekly market data as semiconductor momentum stayed firm.

The confirmation is broad but not extreme: the stock is up 57.8% over four weeks, Market Dynamics shows positive pressure at 1.62, and Relative Strength stands at 82.8. The chart is weekly context, showing the price path over 52 weeks rather than live intraday action.

Continue your research

Explore ALAB across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.

ALAB coverage

Evidence context